{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:17:30Z","timestamp":1781191050765,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1124\/jpet.113.203497","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T03:06:03Z","timestamp":1364267163000},"page":"393-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5\/6 Nephrectomized Rats"],"prefix":"10.1016","volume":"345","author":[{"given":"Nadir","family":"Ulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vavrinec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd W.","family":"Landheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basak","family":"Duman-Dalkilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Gurdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Goris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry","family":"Duin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.E.","family":"van Dokkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Buikema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"van Goor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Henning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.203497_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1440-1797.2011.01451.x","article-title":"Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy","volume":"16","author":"Advani","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1124\/jpet.113.203497_bib2","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/ndt\/13.8.1958","article-title":"Cardiac remodelling in experimental renal failure\u2014an immunohistochemical study","volume":"13","author":"Amann","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.113.203497_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm0102-35","article-title":"Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy","volume":"8","author":"Asakura","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/jpet.113.203497_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes: a consensus approach","volume":"36","author":"Bakris","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.113.203497_bib5","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.0000015076.37047.D9","article-title":"Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study","volume":"105","author":"Bella","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.203497_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/138955709788167619","article-title":"EGF receptor as a drug target in arterial hypertension","volume":"9","author":"Be\u0142towski","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/jpet.113.203497_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vph.2009.04.004","article-title":"Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis","volume":"51","author":"Benter","year":"2009","journal-title":"Vascul Pharmacol"},{"key":"10.1124\/jpet.113.203497_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/01.CIR.100.18.1901","article-title":"Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism","volume":"100","author":"Boffa","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.203497_bib9","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1172\/JCI2132","article-title":"Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin","volume":"101","author":"Chatziantoniou","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.113.203497_bib10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1681\/ASN.2005111163","article-title":"Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy","volume":"17","author":"Chen","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.113.203497_bib11","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","article-title":"Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats","volume":"281","author":"Dorrance","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.113.203497_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1139\/y06-097","article-title":"Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?","volume":"85","author":"Fernandez-Patron","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/jpet.113.203497_bib13","first-page":"H976","article-title":"Epidermal growth factor: a potent vasoconstrictor in experimental hypertension","volume":"276","author":"Florian","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.203497_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1113\/expphysiol.2005.030098","article-title":"Oxidative stress and vascular remodelling","volume":"90","author":"Fortu\u00f1o","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1124\/jpet.113.203497_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1096\/fj.03-0702fje","article-title":"Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition","volume":"18","author":"Fran\u00e7ois","year":"2004","journal-title":"FASEB J"},{"key":"10.1124\/jpet.113.203497_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0008-6363(98)00010-8","article-title":"Enhanced expression of heparin-binding EGF-like growth factor and its receptor in hypertrophied left ventricle of spontaneously hypertensive rats","volume":"38","author":"Fujino","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.113.203497_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00467-008-0978-8","article-title":"Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system","volume":"24","author":"Ghosh","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1124\/jpet.113.203497_bib18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2001.0590041324.x","article-title":"PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis","volume":"59","author":"Gilbert","year":"2001","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.113.203497_bib19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.V5101839","article-title":"The development of hypertension in the remnant kidney model after either pole resection or partial infarction of the kidney","volume":"5","author":"Gretz","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.113.203497_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"10.1124\/jpet.113.203497_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.110.153619","article-title":"Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone\/salt","volume":"57","author":"Griol-Charhbili","year":"2011","journal-title":"Hypertension"},{"key":"10.1124\/jpet.113.203497_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI108079","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle","volume":"56","author":"Grossman","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.113.203497_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1523-1755.2002.00431.x","article-title":"Impaired coronary endothelial function in a rat model of spontaneous albuminuria","volume":"62","author":"Gschwend","year":"2002","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.113.203497_bib24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1681\/ASN.V461354","article-title":"The renin-angiotensin system in the type II diabetic obese Zucker rat","volume":"4","author":"Harker","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.113.203497_bib25","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1158\/1078-0432.CCR-05-0720","article-title":"Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies","volume":"11","author":"Hoekstra","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.113.203497_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.108.180976","article-title":"Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy","volume":"104","author":"Jaffr\u00e9","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/jpet.113.203497_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra011078","article-title":"Subtle acquired renal injury as a mechanism of salt-sensitive hypertension","volume":"346","author":"Johnson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.113.203497_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000065299","article-title":"Preserved endothelium-dependent but impaired beta-adrenergic relaxation of the resistance vessels in experimental renal failure","volume":"10","author":"Jolma","year":"2002","journal-title":"Exp Nephrol"},{"key":"10.1124\/jpet.113.203497_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0735-1097(91)90589-2","article-title":"Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry","volume":"18","author":"Judge","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.113.203497_bib30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.0000030181.63741.56","article-title":"Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense","volume":"106","author":"Kagiyama","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.203497_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.HYP.0000047104.42047.9B","article-title":"Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy","volume":"41","author":"Kagiyama","year":"2003","journal-title":"Hypertension"},{"key":"10.1124\/jpet.113.203497_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.ASN.0000037403.95126.03","article-title":"Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat","volume":"14","author":"Kennedy","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.113.203497_bib33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.HYP.0000215579.81408.8e","article-title":"Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction","volume":"47","author":"Klotz","year":"2006","journal-title":"Hypertension"},{"key":"10.1124\/jpet.113.203497_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1681\/ASN.2004050392","article-title":"Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice","volume":"16","author":"Lassila","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.113.203497_bib35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm1275","article-title":"Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach","volume":"11","author":"Lautrette","year":"2005","journal-title":"Nat Med"},{"key":"10.1124\/jpet.113.203497_bib36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.amjcard.2005.09.136","article-title":"Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events","volume":"97","author":"Liang","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.113.203497_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2004.07.034","article-title":"Diastolic dysfunction: can it be diagnosed by Doppler echocardiography?","volume":"44","author":"Maurer","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.113.203497_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0024-3205(86)90452-2","article-title":"Effect of chronic uremia on the cardiovascular alpha 1 receptor","volume":"39","author":"Meggs","year":"1986","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.203497_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/path.2698","article-title":"Heparin binding epidermal growth factor in renal ischaemia\/reperfusion injury","volume":"221","author":"Mulder","year":"2010","journal-title":"J Pathol"},{"key":"10.1124\/jpet.113.203497_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1291\/hypres.28.925","volume":"28","author":"Nakano","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1124\/jpet.113.203497_bib41","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/hy1201.096815","article-title":"Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension","volume":"38","author":"Northcott","year":"2001","journal-title":"Hypertension"},{"key":"10.1124\/jpet.113.203497_bib42","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1161\/atvb.26.9.1976","article-title":"ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II","volume":"26","author":"Ohtsu","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.113.203497_bib43","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","article-title":"The clinical epidemiology of cardiac disease in chronic renal failure","volume":"10","author":"Parfrey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.113.203497_bib44","doi-asserted-by":"crossref","first-page":"R435","DOI":"10.1152\/ajpregu.00300.2005","article-title":"Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes","volume":"290","author":"Portik-Dobos","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.113.203497_bib45","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/ndt\/15.11.1735","article-title":"Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?","volume":"15","author":"Rump","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.113.203497_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.HYP.0000202487.68969.f7","article-title":"Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats","volume":"47","author":"Schellings","year":"2006","journal-title":"Hypertension"},{"key":"10.1124\/jpet.113.203497_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1440-1681.1996.tb01181.x","article-title":"Elevated epidermal growth factor receptor levels in hypertensive Lyon rat kidney and aorta","volume":"23","author":"Swaminathan","year":"1996","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.113.203497_bib48","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1046\/j.1523-1755.2001.00067.x","article-title":"Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells","volume":"60","author":"Uchiyama-Tanaka","year":"2001","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.113.203497_bib49","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2010.00829.x","article-title":"\u03b11-Adrenoceptor-mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptor","volume":"161","author":"Ulu","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.203497_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000218062","article-title":"Proteinuria-associated endothelial dysfunction is strain dependent","volume":"30","author":"Ulu","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1124\/jpet.113.203497_bib51","first-page":"R189","article-title":"Impaired autoregulation of renal blood flow in the fawn-hooded rat","volume":"276","author":"Van Dokkum","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.203497_bib52","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1097\/01.hjh.0000249699.04113.36","article-title":"Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats","volume":"24","author":"Vettoretti","year":"2006","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.113.203497_bib53","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1523-1755.2004.00955.x","article-title":"Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes","volume":"66","author":"Wassef","year":"2004","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.113.203497_bib54","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/ndt\/gfn233","article-title":"Myocardial infarction does not further impair renal damage in 5\/6 nephrectomized rats","volume":"23","author":"Windt","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.113.203497_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2007.10.060","article-title":"Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5\/6 nephrectomized rats","volume":"580","author":"Windt","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.203497_bib56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/eurjhf\/hfn027","article-title":"Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function","volume":"11","author":"Xu","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1124\/jpet.113.203497_bib57","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/hc3201.094226","article-title":"Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?","volume":"104","author":"Zile","year":"2001","journal-title":"Circulation"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.203497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:22:09Z","timestamp":1739985729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524186089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0022356524186089"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.203497","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5\/6 Nephrectomized Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.203497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}